Impact of the Selective Orexin‐1 Receptor Antagonist ACT‐539313 on the Pharmacokinetics of the CYP3A Probe Drug Midazolam in Healthy Male Subjects
2020 ◽
Vol 60
(7)
◽
pp. 931-941
◽
Keyword(s):
2018 ◽
Vol 59
(1)
◽
pp. 123-130
◽
Keyword(s):
2009 ◽
Vol 49
(10)
◽
pp. 1168-1175
◽
Keyword(s):
2018 ◽
Vol 37
(1)
◽
pp. 139-146
◽
Keyword(s):
2011 ◽
Vol 51
(7)
◽
pp. 1116-1121
◽